Skip to main content
Hikal Ltd. logo

Hikal Ltd. — Investor Relations & Filings

Ticker · HIKAL ISIN · INE475B01022 LEI · 335800OLTGHHYZWTF859 BSE.NS Manufacturing
Open in API
Filings indexed 715 across all filing types
Latest filing 2022-11-09 Earnings Release
Country IN India
Listing BSE.NS HIKAL

About Hikal Ltd.

https://www.hikal.com

Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.

Recent filings

Filing Released Lang Actions
Press Release
Earnings Release Classification · 95% confidence The document is titled as an "Earnings Press Release on the Results of the Company for the quarter and half year ended September 30, 2022." It contains financial highlights such as revenue, EBITDA, and PAT for Q2 FY23, along with segmental performance and management commentary on the results. The document is approximately 9,651 characters long, which is sufficient to include substantive financial data and analysis. It is not merely an announcement of a report or a certification. The content aligns with an Earnings Release, which typically provides initial quarterly financial results and key highlights. Therefore, the document should be classified as an Earnings Release (ER).
2022-11-09 English
Investor Presentation
Regulatory Filings
2022-11-09 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Hikal Limited dated November 9, 2022, addressed to stock exchanges, reporting the outcome of a Board Meeting. It includes approval of unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2022, along with a limited review report by statutory auditors. The document contains extensive financial data such as income statements, segment-wise revenue, balance sheets, and notes on regulatory investigations. The presence of unaudited financial results for a quarter and half year, along with a limited review report, aligns with the characteristics of an Interim / Quarterly Report (IR). The document is not merely an announcement of a report but contains substantive financial data and analysis. Therefore, it should be classified as an Interim / Quarterly Report (IR).
2022-11-09 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 85% confidence The document is a letter dated November 8, 2022, addressed to stock exchanges (BSE Ltd and NSE India) informing about an upcoming earnings conference call scheduled for November 9, 2022. It references the financial and operational performance for the quarter and half year ended September 30, 2022. The document includes dial-in details and participant names for the call. There are no actual financial statements or detailed financial data presented in the document. It is an announcement of the earnings call event, not the earnings release itself or a transcript. Therefore, the document is best classified as a Call Transcript (CT) announcement or invitation. However, since it is only an intimation of the earnings conference call and not the transcript itself, the closest fitting category is Call Transcript (CT) with moderate confidence, as it relates directly to the earnings call event.
2022-11-08 English
Board Meeting — Financial results
Regulatory Filings
2022-11-02 English
General updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It discloses information about a legal notice related to an environmental matter and the company's response. The document is a regulatory announcement providing an update on a legal proceeding and compliance with listing regulations. It does not contain financial statements, detailed financial data, or a full report. It is not an earnings release, annual report, or audit report. The document is a regulatory filing informing the exchanges and public about a material event. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short and it is a disclosure letter, not a full report or presentation.
2022-10-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.